These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

521 related articles for article (PubMed ID: 35352187)

  • 41. Phosphate homeostasis and genetic mutations of familial hypophosphatemic rickets.
    Razali NN; Hwu TT; Thilakavathy K
    J Pediatr Endocrinol Metab; 2015 Sep; 28(9-10):1009-17. PubMed ID: 25894638
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hypophosphatemic rickets: lessons from disrupted FGF23 control of phosphorus homeostasis.
    Goldsweig BK; Carpenter TO
    Curr Osteoporos Rep; 2015 Apr; 13(2):88-97. PubMed ID: 25620749
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Plasma intact fibroblast growth factor 23 level is a useful tool for diagnostic approach of renal hypophosphatemia.
    Giralt M; Chocron S; Ferrer R; Ariceta G
    Pediatr Nephrol; 2021 Apr; 36(4):1025-1028. PubMed ID: 33492457
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Sustained Efficacy and Safety of Burosumab, a Monoclonal Antibody to FGF23, in Children With X-Linked Hypophosphatemia.
    Linglart A; Imel EA; Whyte MP; Portale AA; Högler W; Boot AM; Padidela R; Van't Hoff W; Gottesman GS; Chen A; Skrinar A; Scott Roberts M; Carpenter TO
    J Clin Endocrinol Metab; 2022 Feb; 107(3):813-824. PubMed ID: 34636899
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A PAI-1 antagonist ameliorates hypophosphatemia in the Hyp vitamin D-resistant rickets model mouse.
    Qian C; Ito N; Tsuji K; Sato S; Kikuchi K; Yoshii T; Miyata T; Asou Y
    FEBS Open Bio; 2024 Feb; 14(2):290-299. PubMed ID: 38050660
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Disease Manifestations and Complications in Dutch X-Linked Hypophosphatemia Patients.
    Bosman A; Appelman-Dijkstra NM; Boot AM; de Borst MH; van de Ven AC; de Jongh RT; Bökenkamp A; van den Bergh JP; van der Eerden BCJ; Zillikens MC
    Calcif Tissue Int; 2024 Mar; 114(3):255-266. PubMed ID: 38226986
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The pathophysiology of hypophosphatemia.
    Ito N; Hidaka N; Kato H
    Best Pract Res Clin Endocrinol Metab; 2024 Mar; 38(2):101851. PubMed ID: 38087658
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pathogenic role of Fgf23 in Dmp1-null mice.
    Liu S; Zhou J; Tang W; Menard R; Feng JQ; Quarles LD
    Am J Physiol Endocrinol Metab; 2008 Aug; 295(2):E254-61. PubMed ID: 18559986
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Healing of bone disease in X-linked hypophosphatemic rickets/osteomalacia. Induction and maintenance with phosphorus and calcitriol.
    Harrell RM; Lyles KW; Harrelson JM; Friedman NE; Drezner MK
    J Clin Invest; 1985 Jun; 75(6):1858-68. PubMed ID: 3839245
    [TBL] [Abstract][Full Text] [Related]  

  • 50. What are the benefits of the anti-FGF23 antibody burosumab on the manifestations of X-linked hypophosphatemia in adults in comparison with conventional therapy? A review.
    Lafage-Proust MH
    Ther Adv Rare Dis; 2022; 3():26330040221074702. PubMed ID: 37180412
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Refractory Rickets.
    Chinoy A; Padidela R
    Indian J Pediatr; 2023 Jun; 90(6):574-581. PubMed ID: 37074534
    [TBL] [Abstract][Full Text] [Related]  

  • 52. X-linked hypophosphatemic rickets and nephrocalcinosis: clinical characteristics of a single-center pediatric cohort in North America before and after burosumab.
    Paloian NJ; Boyke-Lohmann LR; Steiner RD
    Front Pediatr; 2024; 12():1430921. PubMed ID: 39156019
    [TBL] [Abstract][Full Text] [Related]  

  • 53. 1,25-Dihydroxyvitamin D Alone Improves Skeletal Growth, Microarchitecture, and Strength in a Murine Model of XLH, Despite Enhanced FGF23 Expression.
    Liu ES; Martins JS; Raimann A; Chae BT; Brooks DJ; Jorgetti V; Bouxsein ML; Demay MB
    J Bone Miner Res; 2016 May; 31(5):929-39. PubMed ID: 26751835
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The efficacy and safety of burosumab in two patients with cutaneous skeletal hypophosphatemia syndrome.
    Sugarman J; Maruri A; Hamilton DJ; Tabatabai L; Luca D; Cimms T; Krolczyk S; Roberts MS; Carpenter TO
    Bone; 2023 Jan; 166():116598. PubMed ID: 36341949
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pharmacological inhibition of fibroblast growth factor (FGF) receptor signaling ameliorates FGF23-mediated hypophosphatemic rickets.
    Wöhrle S; Henninger C; Bonny O; Thuery A; Beluch N; Hynes NE; Guagnano V; Sellers WR; Hofmann F; Kneissel M; Graus Porta D
    J Bone Miner Res; 2013 Apr; 28(4):899-911. PubMed ID: 23129509
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A compound heterozygous mutation in SLC34A3 causes hereditary hypophosphatemic rickets with hypercalciuria in a Chinese patient.
    Chi Y; Zhao Z; He X; Sun Y; Jiang Y; Li M; Wang O; Xing X; Sun AY; Zhou X; Meng X; Xia W
    Bone; 2014 Feb; 59():114-21. PubMed ID: 24246249
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Inherited Fanconi renotubular syndromes: unveiling the intricacies of hypophosphatemic rickets/osteomalacia.
    Ragate DC; Memon SS; Karlekar M; Lila AR; Sarathi V; Jamale T; Thakare S; Patil VA; Shah NS; Bandgar TR
    J Bone Miner Metab; 2024 Mar; 42(2):155-165. PubMed ID: 38310177
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Rickets/Osteomalacia. FGF23-related hypophosphatemic rickets/osteomalacia.].
    Fukumoto S
    Clin Calcium; 2018; 28(10):1313-1317. PubMed ID: 30269112
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Growth pattern in children with X-linked hypophosphatemia treated with burosumab and growth hormone.
    Ertl DA; Le Lorier J; Gleiss A; Trabado S; Bensignor C; Audrain C; Zhukouskaya V; Coutant R; Berkenou J; Rothenbuhler A; Haeusler G; Linglart A
    Orphanet J Rare Dis; 2022 Nov; 17(1):412. PubMed ID: 36371259
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Nephrocalcinosis and kidney function in children and adults with X-linked hypophosphatemia: baseline results from a large longitudinal study.
    Portale AA; Ward L; Dahir K; Florenzano P; Ing SW; Jan de Beur SM; Martin RM; Meza-Martinez AI; Paloian N; Ashraf A; Dixon BP; Khan A; Langman C; Chen A; Wang C; Roberts MS; Tandon PK; Bedrosian C; Imel EA
    J Bone Miner Res; 2024 Sep; 39(10):1493-1502. PubMed ID: 39151033
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.